Clinical Experience with a New Cardioverter Defibrillator Capable of Biphasic Waveform Pulse and Enhanced Data Storage: Results of a Prospective Multicenter Study
Author:
- 1 July 1994
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 17 (7) , 1243-1255
Abstract
A recently introduced cardioverter defibrillator was implanted in 162 patients with refractory ventricular tachyarrhythmias and/or aborted sudden cardiac death. The new device is capable of delivering monophasic and biphasic defibrillation waveform pulses, arrhythmia detection, and therapy in two independently programmable zones, antibradycardia and postshock pacing. Additionally, the device provides enhanced data logs by storing intracardiac “far‐field” electrograms of spontaneous arrhythmic episodes. One hundred sixty‐two patients (mean age 55.5 years; mean left ventricular ejection fraction 36%) were enrolled in this multicenter investigation; coronary artery disease was the primary cardiac disease in 63.6% of the patients, idiopathic cardiomyopathy in 23.8%. Ventricular fibrillation was present in 49.7% of the patients; 29.3% of the patients experienced ventricular fibrillation and ventricular tachycardia; monomorphic ventricuiar tachycardia alone was present in 19.1% of the patients. In 26 patients the device was implanted with standard epicardial defibrillation leads (mean defibrillation threshold 11.5±3.7J). One hundred thirty‐nine patients underwent testing for implantation of a nonthoracotomy system and in 136 (98%), a nonthoracotomy system could be implanted. Defibrillation thresholds with a biphasic waveform (mean 10.2 ± 4.3 J) were lower than with a monophasic waveform (mean 17.4 ± 5.7 J). Two patients (1.2%) died perioperatively (< 30 days). During study time period follow‐up, there were 338 device discharges in 49 patients. Analysis of stored electrograms classified 25% of discharges as inappropriate and due to supraventricular tachyarrhythmias. At a mean follow‐up of 10.8 months, cumulative survival from sudden cardiac death was 98.8%, and survival from all‐cause mortality was 96.3%. This study demonstates the effectiveness of a new implantable cardioverter defibrillator in preventing arrhythmic death and the superior defibrillation efficacy of biphasic waveform pulses, which results in a higher implantation rate of nonthoracotomy systems, as well as the accurate arrhythmia classification made possible by the stored electrograms.Keywords
This publication has 46 references indexed in Scilit:
- Patient Survival Comparison in Three Generations of Automatic Implantable Cardioverter Defibrillators: Review of 12 Years, 25,000 PatientsPacing and Clinical Electrophysiology, 1993
- Improved internal defibrillation efficacy with a biphasic waveformAmerican Heart Journal, 1989
- Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveformAmerican Heart Journal, 1989
- Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillatorThe American Journal of Cardiology, 1988
- Comparative efficacy of transvenous cardioversion and pacing in patients with sustained ventricular tachycardia: a prospective, randomized, crossover study.Circulation, 1985
- Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator.Circulation, 1985
- Transvenous cardioversion of ventricular tachycardia and termination of ventricular fibrillation in manThe American Journal of Cardiology, 1982
- Clinical treatment of life-threatening ventricular tachyarrhythmias with the automatic implantable defibrillatorAmerican Heart Journal, 1981
- Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human BeingsNew England Journal of Medicine, 1980
- Feasibility and Effectiveness of Low-Energy Catheter Defibrillation in ManCirculation, 1973